IN SHORT: Dis-Chem Pharmacies, South Africa’s second-largest pharmacy chain, will open 34 new pharmacy stores in its 2027 financial year as it accelerates its integrated healthcare strategy and expands its primary care, chronic disease management and dispensing footprint. The announcement was reported by Business Day on May 29. Dis-Chem currently operates more than 300 stores nationally and is expanding into adjacent healthcare services including wellness clinics, optometry, chronic disease monitoring and health insurance partnerships.
Dis-Chem Pharmacies is accelerating its expansion at a pace that signals the company’s intention to be a healthcare platform rather than simply a pharmacy chain, planning to open 34 new stores in the financial year ending February 2027 as South Africa’s population ages, chronic disease rates rise and the regulatory environment for pharmacy-led primary care continues to evolve. The store rollout was disclosed by CEO Ivan Saltzman at a recent investor briefing, as reported by Business Day on May 29. The expansion adds approximately 10% to Dis-Chem’s current store count in a single year.
- Dis-Chem currently operates more than 300 stores across South Africa, predominantly in Gauteng, the Western Cape and KwaZulu-Natal. The 34 new stores target underserved suburban and secondary city locations where pharmacy-led primary care meets a structural need that GP-led models cannot serve at the required cost point.
- The expansion is part of a deliberate platform strategy: Dis-Chem stores are increasingly functioning as primary health contact points offering dispensing, chronic disease monitoring, optometry, audiology, wellness assessments and health insurance product distribution under one roof. The model competes less with independent pharmacies and more with the GP-pharmacy-lab visits that South African patients typically make across three separate appointments.
- Dis-Chem’s integrated healthcare ambition intersects directly with the NHI debate. If the Constitutional Court ultimately upholds the NHI Act, pharmacy chains with established primary care infrastructure and a large dispensing network are positioned to become accredited NHI service providers. If the Act is struck down, private-pay integrated care remains the growth model. Either way, Dis-Chem’s footprint and service model positions it well. Africaspoint covered the ConCourt Certificate of Need ruling that stripped a key NHI implementation tool earlier this month: South Africa’s NHI loses in ConCourt.
- The South African pharmacy market is highly consolidated. Clicks and Dis-Chem together command more than 60% of retail pharmacy dispensing revenue. Independent pharmacists have raised concerns about the duopoly’s purchasing power, referral networks and private label product lines. The Pharmacy Alliance and independent operators have lobbied regulators for structural intervention, without significant outcome to date.
- Consumer affordability pressures, driven by elevated fuel costs from the Hormuz disruption, food price inflation and high household debt service costs, are simultaneously making the Dis-Chem value proposition more important and the discretionary health spend components of its revenue more vulnerable. Chronic medication dispensing is non-discretionary. Wellness supplements, cosmetics and discretionary health products are more sensitive to consumer pressure.
The Dis-Chem expansion comes in the context of a South African healthcare system that is genuinely at an inflection point. The NHI Act is in legal challenge, the Certificate of Need tools for geographic distribution have been struck down, private medical scheme membership is under pressure from cost and the uninsured population is growing. Pharmacy-led primary care, which Dis-Chem and Clicks have both been building toward for a decade, may be the most practical near-term solution to the gap between the uninsured population’s health needs and the public health system’s capacity to serve them. Thirty-four new stores in a single year is a serious commitment to that thesis.
The Bigger Picture: Dis-Chem’s 34-store expansion in FY2027 is a market share move, a platform investment, and a bet on South Africa’s healthcare transition simultaneously. The company that runs the most pharmacy stores in the most South African communities is the company that wins the integrated care model, whichever regulatory environment the NHI produces. Clicks will not stand still. The competition for primary care market share in South Africa’s pharmacy sector is intensifying at exactly the moment when the regulatory environment is most uncertain, which means whoever builds the most defensible patient relationship base in the next two years enters the post-NHI era with a durable advantage.
Source: Business Day, May 29 2026
